Pfizer Inc.
Site specific HER2 antibody drug conjugates
Last updated:
Abstract:
The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
Status:
Grant
Type:
Utility
Filling date:
21 Nov 2016
Issue date:
23 Jun 2020